American Vietnamese Biotech Incorporation announced earnings results for the third quarter ended September 30, 2019. For the third quarter, the company announced total revenue was VND 124,371.404 million compared to VND 113,646.661 million a year ago. Operating income was VND 56,963.452 million compared to VND 68,068.069 million a year ago. Net income was VND 55,623.194 million compared to VND 66,543.913 million a year ago. Basic earnings per share was VND 1,761 compared to VND 2,454 a year ago. For the nine months, total revenue was VND 307,013.588 million compared to VND 164,179.966 million a year ago. Operating income was VND 111,433.384 million compared to VND 97,081.262 million a year ago. Net income was VND 108,580.603 million compared to VND 94,709.615 million a year ago. Basic earnings per share was VND 3,714 compared to VND 3,563 a year ago.